510(k) K172957
K172957 is an FDA 510(k) premarket notification submitted by Kawasumi Laboratories, Inc. for the device "Kawasumi Laboratories Blood Drawing Kit (BDK) System". The FDA issued a decision of Substantially Equivalent on September 28, 2018. The device falls under product code KSB (Set, Transfer (Blood/Plasma)), a Class II device regulated under 21 CFR 864.9875. Kawasumi Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 28, 2018
- Date Received
- September 26, 2017
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Set, Transfer (Blood/Plasma)
- Device Class
- Class II
- Regulation Number
- 864.9875
- Review Panel
- HE
- Submission Type